Literature DB >> 7549872

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

J N Varghese1, V C Epa, P M Colman.   

Abstract

The three-dimensional X-ray structure of a complex of the potent neuraminidase inhibitor 4-guanidino-Neu5Ac2en and influenza virus neuraminidase (Subtype N9) has been obtained utilizing diffraction data to 1.8 A resolution. The interactions of the inhibitor, solvent water molecules, and the active site residues have been accurately determined. Six water molecules bound in the native structure have been displaced by the inhibitor, and the active site residues show no significant conformational changes on binding. Sialic acid, the natural substrate, binds in a half-chair conformation that is isosteric to the inhibitor. The conformation of the inhibitor in the active site of the X-ray structure concurs with that obtained by theoretical calculations and validates the structure-based design of the inhibitor. Comparison of known high-resolution structures of neuraminidase subtypes N2, N9, and B shows good structural conservation of the active site protein atoms, but the location of the water molecules in the respective active sites is less conserved. In particular, the environment of the 4-guanidino group of the inhibitor is strongly conserved and is the basis for the antiviral action of the inhibitor across all presently known influenza strains. Differences in the solvent structure in the active site may be related to variation in the affinities of inhibitors to different subtypes of neuraminidase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549872      PMCID: PMC2143140          DOI: 10.1002/pro.5560040606

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  15 in total

1.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.

Authors:  J N Varghese; J L McKimm-Breschkin; J B Caldwell; A A Kortt; P M Colman
Journal:  Proteins       Date:  1992-11

2.  Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.

Authors:  P M Colman; W G Laver; J N Varghese; A T Baker; P A Tulloch; G M Air; R G Webster
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

Review 3.  MOPAC: a semiempirical molecular orbital program.

Authors:  J J Stewart
Journal:  J Comput Aided Mol Des       Date:  1990-03       Impact factor: 3.686

4.  Three-dimensional structures of influenza virus neuraminidase-antibody complexes.

Authors:  P M Colman; W R Tulip; J N Varghese; P A Tulloch; A T Baker; W G Laver; G M Air; R G Webster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1989-06-12       Impact factor: 6.237

5.  Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A.

Authors:  J N Varghese; R G Webster; W G Laver; P M Colman
Journal:  J Mol Biol       Date:  1988-03-05       Impact factor: 5.469

6.  Slow-binding inhibition of sialidase from influenza virus.

Authors:  M S Pegg; M von Itzstein
Journal:  Biochem Mol Biol Int       Date:  1994-04

7.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

8.  Influenza virus neuraminidase with hemagglutinin activity.

Authors:  W G Laver; P M Colman; R G Webster; V S Hinshaw; G M Air
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

9.  Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain.

Authors:  S Crennell; E Garman; G Laver; E Vimr; G Taylor
Journal:  Structure       Date:  1994-06-15       Impact factor: 5.006

10.  Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.

Authors:  P Bossart-Whitaker; M Carson; Y S Babu; C D Smith; W G Laver; G M Air
Journal:  J Mol Biol       Date:  1993-08-20       Impact factor: 5.469

View more
  39 in total

1.  Analysis of inhibitor binding in influenza virus neuraminidase.

Authors:  B J Smith; P M Colman; M Von Itzstein; B Danylec; J N Varghese
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Development and testing of a de novo drug-design algorithm.

Authors:  Eric Pellegrini; Martin J Field
Journal:  J Comput Aided Mol Des       Date:  2003-10       Impact factor: 3.686

3.  Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.

Authors:  J N Varghese; P M Colman; A van Donkelaar; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

Authors:  Gallen B Triana-Baltzer; Rebecca L Sanders; Maria Hedlund; Kellie A Jensen; Laura M Aschenbrenner; Jeffrey L Larson; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2010-11-21       Impact factor: 5.790

Review 5.  Winning the arms race by improving drug discovery against mutating targets.

Authors:  Amy C Anderson
Journal:  ACS Chem Biol       Date:  2011-11-11       Impact factor: 5.100

6.  Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Authors:  Takashi Suzuki; Tadanobu Takahashi; Chao-Tan Guo; Kazuya I-P Jwa Hidari; Daisei Miyamoto; Hideo Goto; Yoshihiro Kawaoka; Yasuo Suzuki
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  DOCK 6: Impact of new features and current docking performance.

Authors:  William J Allen; Trent E Balius; Sudipto Mukherjee; Scott R Brozell; Demetri T Moustakas; P Therese Lang; David A Case; Irwin D Kuntz; Robert C Rizzo
Journal:  J Comput Chem       Date:  2015-06-05       Impact factor: 3.376

8.  Scoring ensembles of docked protein:ligand interactions for virtual lead optimization.

Authors:  Janet L Paulsen; Amy C Anderson
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

9.  T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.

Authors:  Maki Kiso; Kazumi Takahashi; Yuko Sakai-Tagawa; Kyoko Shinya; Saori Sakabe; Quynh Mai Le; Makoto Ozawa; Yousuke Furuta; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.